Fullerton Health Australia is pleased to announce the appointment of Dr Daniel Chan as the new Chairman of its Board of Directors with effect from 18 July 2020. He will provide Board-level direction to the Australia leadership team, especially in the Primary Care division.
Dr Daniel is the Co-Founder, President of Fullerton Health China, and Executive Director at Fullerton Health. He was Regional Managing Director, Singapore and Malaysia until February 2018.
He was previously Chief Operating Officer of Parkway East Hospital from 2008 to 2010, and Vice President (Business Development) and Medical Director at Parkway Shenton Singapore from 2004 to 2008.
Dr Daniel holds a Master of Business Administration (MBA) from the University of Liverpool, Family Physician qualification from the Singapore Medical Council and Advanced Management Programme from Harvard Business School. Dr Daniel also holds a Bachelor of Medicine and Bachelor of Surgery (MBBS) from Imperial College of Science, Technology and Medicine and a Graduate Diploma in Occupational Medicine from the National University of Singapore.
Mr Ho Kuen Loon remains on the Fullerton Health Australia Board as an Executive Director, and continues in his role as Fullerton Health Group Chief Executive Officer based in Singapore.
Mr Steven Harvey, Fullerton Health Australia’s Managing Director, said, “I am pleased that Dr Daniel Chan has been appointed as Chairman of the Fullerton Health Australia Board. As Co-Founder of Fullerton Health and respected Physician, Dr Daniel brings important insights and experience to support our leadership team, particularly our primary care division where we own and operate over 60 medical centres across the country. I look forward to working with Dr Daniel as we continue to navigate the current challenges of the global Coronavirus pandemic, whilst remaining focussed on opportunities that will advance the company into the new era of healthcare in Australia.”